We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Axcelis (ACLS) Purion Solution Continues to Gain Traction
Read MoreHide Full Article
Axcelis Technologies (ACLS - Free Report) recently announced that it completed the 500th shipment of its Purion ion implanter system to a prominent semiconductor device maker based in North America.
Axcelis further added that the increasing Purion installed base will provide strong growth opportunity for the company’s Customer Solutions & Innovation aftermarket business.
Axcelis’ flagship product Purion ion implanter is designed to overcome challenges of fab processes at 10 nanometer or less. Purion provides customers with highest standards of purity, precision and productivity at the lowest cost of ownership, highlighted Axcelis.
The company’s advanced Purion Product Extensions are aiding Axcelis to gain share in the sensor and power device manufacturing space. With these product extensions in its portfolio, Axcelis boasts implant products for both the silicon IGBT and silicon carbide power device market segments.
The transition to electric vehicles is driving the silicon carbide power device market and in turn boosting demand for Purion suite of products. Driven by solid growth of the Purion Power Series product line, the power device market segment represented 39% of the company’s shipped systems revenues in 2022.
For the first quarter of 2023, Axcelis expects revenues of $240 million while gross margin is expected to be nearly 41.5%. Operating profit is expected to be $48 million while earnings per share for the first quarter are expected to be $1.25. For the full year, Axcelis anticipates revenues to be more than $1 billion.
For the fourth quarter of 2022, the company reported revenues of $266.1 million, up 29.3% year over year. The top-line performance was driven by continued strength in Purion product family. The company reported earnings of $1.71 per share compared with $1.05 in the prior-year quarter.
At present, ACLS carries a Zacks Rank #3 (Hold). Shares of the company have surged 105.5% against the sub-industry’s decline of 16.7% in the past year.
The Zacks Consensus Estimate for Arista Networks’ 2023 earnings is pegged at $5.85 per share, rising 10.9% in the past 60 days. The long-term earnings growth rate is anticipated to be 14.2%.
Arista Networks’ earnings beat the Zacks Consensus Estimate in the last four quarters, the average being 14.2%. Shares of ANET have increased 22.6% in the past year.
The Zacks Consensus Estimate for Perion’s 2023 earnings is pegged at $2.69 per share, rising 16% in the past 60 days. The long-term earnings growth rate is anticipated to be 25%.
Perion’s earnings beat the Zacks Consensus Estimate in all the last four quarters, the average being 31.7%. Shares of PERI have increased 56.7% in the past year.
The Zacks Consensus Estimate for Pegasystems’ 2023 earnings is pegged at $1.35 per share, rising 66.7% in the past 60 days.
Pegasystems’ earnings beat the Zacks Consensus Estimate in two of the trailing four quarters, the average surprise being 11.2%. Shares of PEGA have declined 38.2% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Axcelis (ACLS) Purion Solution Continues to Gain Traction
Axcelis Technologies (ACLS - Free Report) recently announced that it completed the 500th shipment of its Purion ion implanter system to a prominent semiconductor device maker based in North America.
Axcelis further added that the increasing Purion installed base will provide strong growth opportunity for the company’s Customer Solutions & Innovation aftermarket business.
Axcelis’ flagship product Purion ion implanter is designed to overcome challenges of fab processes at 10 nanometer or less. Purion provides customers with highest standards of purity, precision and productivity at the lowest cost of ownership, highlighted Axcelis.
The company’s advanced Purion Product Extensions are aiding Axcelis to gain share in the sensor and power device manufacturing space. With these product extensions in its portfolio, Axcelis boasts implant products for both the silicon IGBT and silicon carbide power device market segments.
Axcelis Technologies, Inc. Price and Consensus
Axcelis Technologies, Inc. price-consensus-chart | Axcelis Technologies, Inc. Quote
The transition to electric vehicles is driving the silicon carbide power device market and in turn boosting demand for Purion suite of products. Driven by solid growth of the Purion Power Series product line, the power device market segment represented 39% of the company’s shipped systems revenues in 2022.
For the first quarter of 2023, Axcelis expects revenues of $240 million while gross margin is expected to be nearly 41.5%. Operating profit is expected to be $48 million while earnings per share for the first quarter are expected to be $1.25. For the full year, Axcelis anticipates revenues to be more than $1 billion.
For the fourth quarter of 2022, the company reported revenues of $266.1 million, up 29.3% year over year. The top-line performance was driven by continued strength in Purion product family. The company reported earnings of $1.71 per share compared with $1.05 in the prior-year quarter.
At present, ACLS carries a Zacks Rank #3 (Hold). Shares of the company have surged 105.5% against the sub-industry’s decline of 16.7% in the past year.
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks in the broader technology space are Arista Networks (ANET - Free Report) , Perion Network (PERI - Free Report) and Pegasystems (PEGA - Free Report) , each presently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Arista Networks’ 2023 earnings is pegged at $5.85 per share, rising 10.9% in the past 60 days. The long-term earnings growth rate is anticipated to be 14.2%.
Arista Networks’ earnings beat the Zacks Consensus Estimate in the last four quarters, the average being 14.2%. Shares of ANET have increased 22.6% in the past year.
The Zacks Consensus Estimate for Perion’s 2023 earnings is pegged at $2.69 per share, rising 16% in the past 60 days. The long-term earnings growth rate is anticipated to be 25%.
Perion’s earnings beat the Zacks Consensus Estimate in all the last four quarters, the average being 31.7%. Shares of PERI have increased 56.7% in the past year.
The Zacks Consensus Estimate for Pegasystems’ 2023 earnings is pegged at $1.35 per share, rising 66.7% in the past 60 days.
Pegasystems’ earnings beat the Zacks Consensus Estimate in two of the trailing four quarters, the average surprise being 11.2%. Shares of PEGA have declined 38.2% in the past year.